Oxford University to test Covid-19 vaccine safety in kids
Published
This trial will assess if children and young adults aged 6-17 years develop a good immune response with the ChAdOx1 nCoV-19 vaccine.
Full ArticlePublished
This trial will assess if children and young adults aged 6-17 years develop a good immune response with the ChAdOx1 nCoV-19 vaccine.
Full ArticleAfter AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination..
It began as a shudder through the scientific and public health establishments. A new variant of the novel coronavirus SARS-CoV-2..